Rebordosa, C. ., Plana, E. ., Rubino, A. ., Aguado, J. ., Martinez, D. ., Lei, A. ., … Rivero-Ferrer, E. . (2022). Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists. Int J Chron Obstruct Pulmon Dis, 17, 1715–1733. http://doi.org/10.2147/copd.s363997
E. Plana
First name
E.
Last name
Plana
Rivero-Ferrer, E. ., Olesen, M. ., Plana, E. ., Aguado, J. ., Saigi-Morgui, N. ., Rubino, A. ., … Rebordosa, C. . (2022). Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany. Clin Drug Investig. http://doi.org/10.1007/s40261-022-01120-2
Afonso, A. ., Schmiedl, S. ., Becker, C. ., Tcherny-Lessenot, S. ., Primatesta, P. ., Plana, E. ., … Rottenkolber, M. . (2016). A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-016-2071-8
Margulis, A. V., Fortuny, J. ., Kaye, J. A., Calingaert, B. ., Reynolds, M. ., Plana, E. ., … Arana, A. . (2018). Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United Kingdom. Epidemiology. http://doi.org/10.1097/ede.0000000000000856
Kaye, J. A., Margulis, A. V., Fortuny, J. ., McQuay, L. J., Plana, E. ., Bartsch, J. L., … Arana, A. . (2017). Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias. Pharmacotherapy. http://doi.org/10.1002/phar.1932
Margulis, A. V., Fortuny, J. ., Kaye, J. A., Calingaert, B. ., Reynolds, M. ., Plana, E. ., … Arana, A. . (2018). Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United Kingdom. Epidemiology. http://doi.org/10.1097/ede.0000000000000786
Cainzos-Achirica, M. ., Varas-Lorenzo, C. ., Pottegard, A. ., Asmar, J. ., Plana, E. ., Rasmussen, L. ., … Pladevall-Vila, M. . (2018). Methodological challenges when evaluating potential off-label prescribing of drugs using electronic health care databases: A case study of dabigatran etexilate in Europe. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4416
Rebordosa, C. ., Plana, E. ., Aguado, J. ., Thomas, S. ., Garcia-Gil, E. ., Perez-Gutthann, S. ., & Castellsague, J. . (2018). GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD). Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4448
Rebordosa, C. ., Aguado, J. ., Plana, E. ., Thomas, S. ., Frances, A. ., Lei, A. ., … Castellsague, J. . (2019). Use of aclidinium did not increase the risk of death in a noninterventional cohort study in the Clinical Practice Research Datalink (CPRD), United Kingdom. Respir Med. http://doi.org/10.1016/j.rmed.2019.04.018
Fortuny, J. ., Gilsenan, A. ., Cainzos-Achirica, M. ., Cantero, O. F., Flynn, R. W. V., Garcia-Rodriguez, L. ., … Andrews, E. B. (2019). Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350. Drug Saf. http://doi.org/10.1007/s40264-019-00836-z